Effect of Aspirin on Protein Binding and Tissue Disposition of Oligonucleotide Phosphorothioate in Rats
- 1 January 1998
- journal article
- research article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 5 (4) , 303-312
- https://doi.org/10.3109/10611869808995883
Abstract
Pharmacokinetic studies of phosphorothioate oligodeoxynucleotides (PS-oligonucleotides) in animals show that following intravenous administration, PS-oligonucleotide clears out rapidly from the plasma and is distributed to majority of the organs. PS-oligonucleotides are bound to plasma proteins extensively. This study was aimed to determine the effect of aspirin, a commonly used drug, on pharmacokinetics of PS-oligonucleotides. In the present study, PS-oligonucleotide was administered to rats that had received aspirin by gavage. Pharmacokinetic study shows that if PS-oligonucleotide was administered following aspirin administration in rats, a) plasma pharmacokinetic parameters (t1/2α?, t1/2β, AUC, etc.) had lower values, b) tissue disposition was different, and c) rate and route of elimination was affected in animals compared to rats receiving PS-oligonucleotide alone. This finding suggests that pharmacokinetics of PS-oligonucleotides can be affected with certain class of drugs, which may have direct impact on biological activity and safety.Keywords
This publication has 20 references indexed in Scilit:
- Antisense oligonucleotides: towards clinical trialsTrends in Biotechnology, 1996
- Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administrationBiochemical Pharmacology, 1995
- Characterization of Binding Sites, Extent of Binding, and Drug Interactions of Oligonucleotides with AlbuminAntisense Research and Development, 1995
- Review of in vivo pharmacokinetics and toxicology of phosphorothioate oligonucleotidesJournal of Clinical Laboratory Analysis, 1995
- Pharmacokinetics of Antisense OligonucleotidesClinical Pharmacokinetics, 1995
- Pharmacokinetics of an Antisense Phosphorothioate Oligodeoxynucleotide againstrevfrom Human Immunodeficiency Virus Type 1 in the Adult Male Rat Following Single Injections and Continuous InfusionAntisense Research and Development, 1994
- Large-Scale Synthesis, Purification, and Analysis of Oligodeoxynucleotide PhosphorothioatesAntisense Research and Development, 1994
- Systemic Administration of a Phosphorothioate Oligonucleotide with a Sequence Complementary to p53 for Acute Myelogenous Leukemia and Myelodysplastic Syndrome: Initial Results of a Phase I TrialAntisense Research and Development, 1993
- Atomic structure and chemistry of human serum albuminNature, 1992
- Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.Proceedings of the National Academy of Sciences, 1991